No insider purchase over the last 90 days. The latest, by 조혜림, was filed 02 Jun 2026.
Hana Pharm Co., Ltd.: what insiders have been doing
Hana Pharm Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through DART (FSS). Over the twelve months to 10 November 2026, 7 filings were filed, from 6 insiders.
Open-market activity splits into 5 purchases totalling €978k and 2 sales; 5 insiders sit on the buying side and 2 insiders on the selling side. No amount is published for 5 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 2 senior executives and 1 board member. Biggest ticket of the year: €689k, bought by 조혜림 and made public on 2 June 2026.
In the case of 2 purchases, another manager of the company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The clock since the last published purchase (2 June 2026) now reads 161 days.
With 7 filings in twelve months, the company is in line with the median of 7 filings across the 2,630 companies we follow on the same exchange. Since 2021, the database holds 17 purchases and 2 sales by insiders of the company.
Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -6.3%Entry ₩9,100 · Close at T+90 ₩8,530
- -6.3%Entry ₩9,100 · Close at T+90 ₩8,530
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 2,022 sharesShareKRXDART:20260827000085
- 123,342 shares@ ₩9,681.5916100.0% of flowShareKRXDART:20260602000420Canonical exit: 21 Jul 2026 (T+90)
- 51,233 shares@ ₩9,756.6184100.0% of flowShareKRXDART:20260602000415Canonical exit: 27 Jul 2026 (T+90)
- ShareKRXDART:20260220002149Canonical exit: 13 May 2026 (T+90)
- ShareKRXDART:20260211000953Canonical exit: 7 May 2026 (T+90)
- ShareKRXDART:20260211000932Canonical exit: 7 May 2026 (T+90)
- ShareKRXDART:20260114000279
- 10,000 sharesKRXDART:20241028000029Canonical exit: 20 Jan 2025 (T+90)
- ShareKRXDART:20241028000035Canonical exit: 20 Jan 2025 (T+90)
- ShareKRXDART:20240809000129Canonical exit: 3 Nov 2024 (T+90)
- ShareKRXDART:20240808000179Canonical exit: 30 Oct 2024 (T+90)
- ShareKRXDART:20240709000108Canonical exit: 1 May 2024 (T+90)
- ●Executives0DART
- ShareKRXDART:20231229000506
- ShareKRXDART:20230728000387
- ShareKRXDART:20230602000361
- 10,000 sharesKRXDART:20230407002128Canonical exit: 6 Jul 2023 (T+90)
- 10,000 sharesKRXDART:20230328000895Canonical exit: 26 Jun 2023 (T+90)
- 10,000 sharesKRXDART:20221214000280Canonical exit: 14 Mar 2023 (T+90)
- ShareKRXDART:20221017000194
- 10,000 sharesKRXDART:20220824000322Canonical exit: 22 Nov 2022 (T+90)
- 10,000 sharesKRXDART:20220725000229Canonical exit: 23 Oct 2022 (T+90)
- 10,000 sharesKRXDART:20220608000236Canonical exit: 6 Sept 2022 (T+90)
- ●Executives0DART
- ShareKRXDART:20210524000258
25 of 31 declarations
About Hana Pharm Co., Ltd.
하나제약 is a healthcare and pharmaceutical company listed on the XKRX. It specializes in the development and manufacturing of pharmaceutical products.
